Tomofumi Igarashi

1.2k total citations
38 papers, 931 citations indexed

About

Tomofumi Igarashi is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Tomofumi Igarashi has authored 38 papers receiving a total of 931 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pulmonary and Respiratory Medicine, 13 papers in Oncology and 8 papers in Molecular Biology. Recurrent topics in Tomofumi Igarashi's work include Lymphoma Diagnosis and Treatment (5 papers), Medical Imaging and Pathology Studies (4 papers) and Neutropenia and Cancer Infections (4 papers). Tomofumi Igarashi is often cited by papers focused on Lymphoma Diagnosis and Treatment (5 papers), Medical Imaging and Pathology Studies (4 papers) and Neutropenia and Cancer Infections (4 papers). Tomofumi Igarashi collaborates with scholars based in Japan, United States and Australia. Tomofumi Igarashi's co-authors include T. Ohtsu, Shosaku Abe, Yosuke Sasaki, Hiroshi Tanaka, Kensei Tobinai, Yukio Kobayashi, Michinori Ogura, T. Kinoshita, Y Morishima and Takashi Murate and has published in prestigious journals such as Blood, CHEST Journal and British Journal of Cancer.

In The Last Decade

Tomofumi Igarashi

38 papers receiving 905 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Tomofumi Igarashi 263 250 248 191 131 38 931
M. R. Moore 428 1.6× 287 1.1× 296 1.2× 119 0.6× 55 0.4× 41 1.1k
Riccardo Ghio 273 1.0× 150 0.6× 161 0.6× 286 1.5× 52 0.4× 93 1.2k
C. F. Lynch 265 1.0× 198 0.8× 234 0.9× 59 0.3× 99 0.8× 21 1.1k
Robert Bagin 188 0.7× 184 0.7× 160 0.6× 77 0.4× 134 1.0× 25 1.1k
Mark P. McLaughlin 183 0.7× 243 1.0× 95 0.4× 149 0.8× 84 0.6× 25 1.0k
Nascimento Costa 233 0.9× 164 0.7× 218 0.9× 77 0.4× 31 0.2× 49 981
Kyung Duk Park 199 0.8× 185 0.7× 138 0.6× 239 1.3× 27 0.2× 103 1.2k
Felix Keil 299 1.1× 104 0.4× 115 0.5× 158 0.8× 37 0.3× 81 1.1k
Z Weshler 210 0.8× 115 0.5× 65 0.3× 93 0.5× 136 1.0× 55 887
G Leverger 365 1.4× 488 2.0× 527 2.1× 141 0.7× 111 0.8× 77 1.9k

Countries citing papers authored by Tomofumi Igarashi

Since Specialization
Citations

This map shows the geographic impact of Tomofumi Igarashi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomofumi Igarashi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomofumi Igarashi more than expected).

Fields of papers citing papers by Tomofumi Igarashi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomofumi Igarashi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomofumi Igarashi. The network helps show where Tomofumi Igarashi may publish in the future.

Co-authorship network of co-authors of Tomofumi Igarashi

This figure shows the co-authorship network connecting the top 25 collaborators of Tomofumi Igarashi. A scholar is included among the top collaborators of Tomofumi Igarashi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomofumi Igarashi. Tomofumi Igarashi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tobinai, Kensei, Tomofumi Igarashi, Kuniaki Itoh, et al.. (2004). Japanese multicenter phase II and pharmacokinetic study of rituximab in relapsed or refractory patients with aggressive B-cell lymphoma. Annals of Oncology. 15(5). 821–830. 89 indexed citations
2.
Igarashi, Tomofumi, Yukio Kobayashi, Michinori Ogura, et al.. (2002). Factors affecting toxicity, response and progression-free survival in relapsed patients with indolent B-cell lymphoma and mantle cell lymphoma treated with rituximab: a Japanese phase II study. Annals of Oncology. 13(6). 928–943. 102 indexed citations
3.
Tanaka, Hiroshi, et al.. (2002). Role of Interleukin-18 and T-helper Type 1 Cytokines in the Development of Mycoplasma pneumoniae Pneumonia in Adults. CHEST Journal. 121(5). 1493–1497. 88 indexed citations
4.
Yamada, Gen, et al.. (2001). Centrilobular Nodules Correlate With Air Trapping in Diffuse Panbronchiolitis During Erythromycin Therapy. CHEST Journal. 120(1). 198–202. 8 indexed citations
5.
Osanai, Makoto, Tomofumi Igarashi, & Yutaka Yoshida. (2001). Unique Cellular Features in Atypical Adenomatous Hyperplasia of the Lung: Ultrastructural Evidence of Its Cytodifferentiation. Ultrastructural Pathology. 25(5). 367–373. 7 indexed citations
6.
Tanaka, Hiroshi, et al.. (2000). Effects of naturally-occurring acid fog on inflammatory mediators in airway and pulmonary functions in asthmatic patients. Respiratory Medicine. 94(10). 935–942. 14 indexed citations
7.
Itoh, Kazuyuki, T. Ohtsu, Hisashi Wakita, et al.. (2000). Dose-escalation study of CHOP with or without prophylactic G-CSF in aggressive non-Hodgkin's lymphoma. Annals of Oncology. 11(10). 1241–1248. 21 indexed citations
8.
Narabayashi, Masaru, Takashi Fukutomi, Yutaka Tokuda, et al.. (1999). A Dose-finding Study of Lenograstim (Glycosylated rHuG-CSF) for Peripheral Blood Stem Cell Mobilization during Postoperative Adjuvant Chemotherapy in Patients with Breast Cancer. Japanese Journal of Clinical Oncology. 29(6). 285–290. 8 indexed citations
9.
Imoto, Shigeru, H Ohkura, Kokichi Sugano, et al.. (1998). Determination of Cytosol c-erbB-2 Protein in Breast Cancer by Sandwich Enzyme Immunoassay. Japanese Journal of Clinical Oncology. 28(2). 92–96. 8 indexed citations
10.
Igarashi, Tomofumi, Kuniaki Itoh, T. Ohtsu, et al.. (1998). Successful Treatment by Radiation and Hormone Therapy of Isolated Local Recurrence of Breast Cancer 24 Years After Mastectomy Accompanied by Immune Thrombocytopenia: a Case Report. Japanese Journal of Clinical Oncology. 28(4). 270–275. 14 indexed citations
11.
Ohtsu, T., et al.. (1998). Unexpected Hepatotoxicities in Patients with Non-Hodgkin's Lymphoma Treated with Irinotecan (CPT-11) and Etoposide. Japanese Journal of Clinical Oncology. 28(8). 502–506. 13 indexed citations
12.
Tobinai, Kensei, Yukio Kobayashi, Masaru Narabayashi, et al.. (1998). Feasibility and pharmacokinetic study of a chimeric anti-CD20 monoclonal antibody (IDEC-C2B8, rituximab) in relapsed B-cell lymphoma. Annals of Oncology. 9(5). 527–534. 126 indexed citations
13.
Tanaka, Hiroshi, et al.. (1998). Acid fog and hospital visits for asthma: an epidemiological study. European Respiratory Journal. 11(6). 1301–1306. 22 indexed citations
14.
Ando, Masashi, Toru Watanabe, Yosuke Sasaki, et al.. (1998). A phase I trial of docetaxel and 5-day continuous infusion of 5-fluorouracil in patients with advanced or recurrent breast cancer. British Journal of Cancer. 77(11). 1937–1943. 17 indexed citations
15.
Itoh, Kuniaki, Hisashi Wakita, Yuko Watanabe, et al.. (1998). Successful Treatment with Nedaplatin in Patients with Ovarian Cancer that Recurred After Platinum-containing Chemotherapy: Report of Two Cases. Japanese Journal of Clinical Oncology. 28(5). 343–346. 4 indexed citations
16.
Igarashi, Tomofumi, Saki Shimizu, Kazuhiro Morishita, et al.. (1998). Acute Myelogenous Leukemia with Monosomy 7, inv(3) (q21q26), Involving Activated EVI 1 Gene Occurring after a Complete Remission of Lymphoblastic Lymphoma: A Case Report. Japanese Journal of Clinical Oncology. 28(11). 688–695. 3 indexed citations
17.
Itoh, Kuniaki, Yosuke Sasaki, Hirofumi Fujii, et al.. (1997). Patients in phase I trials of anti-cancer agents in Japan: motivation, comprehension and expectations. British Journal of Cancer. 76(1). 107–113. 54 indexed citations
18.
Nakano, Takashi, Harumichi Ikegami, Shôji Nakamura, et al.. (1996). A phase II study of cisplatin, vindesine and continuously infused 5-fluorouracil in the treatment of advanced non-small-cell lung cancer. British Journal of Cancer. 73(9). 1096–1100. 2 indexed citations
19.
Shijubo, Noriharu, Michio Hirasawa, Hiroko Sasaki, et al.. (1996). Elevated Progastrin-Releasing Peptide(31-98) Concentrations in Pleural Effusions due to Small-Cell Lung Carcinoma. Respiration. 63(2). 106–110. 7 indexed citations
20.
Tanaka, Hiroshi, et al.. (1995). Lymphoepithelial Cysts in the Mediastinum with an Opening to the Trachea. Respiration. 62(2). 110–113. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M. R. Moore Breakdown of academic impact, for papers by Riccardo Ghio Breakdown of academic impact, for papers by C. F. Lynch Breakdown of academic impact, for papers by Robert Bagin Breakdown of academic impact, for papers by Mark P. McLaughlin Breakdown of academic impact, for papers by Nascimento Costa Breakdown of academic impact, for papers by Kyung Duk Park Breakdown of academic impact, for papers by Felix Keil Breakdown of academic impact, for papers by Z Weshler Breakdown of academic impact, for papers by G Leverger
Rankless by CCL
2026